NASDAQ:TCON
TRACON Pharmaceuticals Stock News
$1.81
+0.100 (+5.85%)
At Close: May 02, 2024
Wall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for April 2024
06:30am, Wednesday, 10'th Apr 2024
Now could be a great time for investors to consider stacking up on penny stocks. These companies often have significant growth potential.
TRACON to Report Fourth Quarter and Year-End 2023 Financial Results and Provide Corporate Update on March 5, 2024
04:02pm, Wednesday, 28'th Feb 2024
SAN DIEGO, Feb. 28, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development pla
Why Is Tracon Pharmaceuticals (TCON) Stock Up 19% Today?
07:55am, Tuesday, 21'st Nov 2023
Tracon Pharmaceuticals (NASDAQ: TCON ) stock is rocketing higher on Tuesday as investors react to a licensing agreement for its product development platform ( PDP ). According to a press release from
Why Is Tracon Pharmaceuticals (TCON) Stock Down 22% Today?
09:29am, Monday, 13'th Nov 2023
Tracon Pharmaceuticals (NASDAQ: TCON ) stock is falling on Monday as the company's shares retreat from a massive rally on Friday. That rally saw shares of TCON stock climb 43.9% higher during normal
Why Is Tracon Pharmaceuticals (TCON) Stock Up 130% Today?
07:45am, Friday, 10'th Nov 2023
Tracon Pharmaceuticals (NASDAQ: TCON ) stock is rocketing higher on Friday after the biopharmaceutical company announced results for the third quarter of 2023. Tracon Pharmaceuticals starts its report
TRACON Pharmaceuticals, Inc. (TCON) Q3 2023 Earnings Call Transcript
09:10pm, Thursday, 09'th Nov 2023
TRACON Pharmaceuticals, Inc. (NASDAQ:TCON ) Q3 2023 Results Conference Call November 9, 2023 4:30 PM ET Company Participants Dr. Charles Theuer - President and CEO Scott Brown - CFO Conference Call Pa
TRACON Pharmaceuticals Announces Participation at Upcoming Investor Conferences
04:02pm, Tuesday, 05'th Sep 2023
SAN DIEGO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development pl
7 F-Rated Biotech Stocks You Shouldn't Touch With a 10-Foot Pole
07:20am, Friday, 25'th Aug 2023
Investing in biotech stocks can be challenging. The rewards can be great when your company hits on a popular drug, treatment or product.
TRACON Pharmaceuticals, Inc. (TCON) Q2 2023 Earnings Call Transcript
06:50pm, Monday, 14'th Aug 2023
TRACON Pharmaceuticals, Inc. (NASDAQ:TCON ) Q2 2023 Earnings Call August 14, 2023 4:30 PM ET Company Participants Charles P. Theuer - President and CEO Scott B.
Penny Stocks To Buy Now? 3 With Ratings Up To 1,742%
10:48am, Thursday, 03'rd Aug 2023
In a stock market characterized by growing unpredictability, traders are leaning on every possible resource. One such indispensable tool, whether dealing with penny stocks or more expensive shares, is
TRACON to Report Second Quarter 2023 Financial Results and Provide Corporate Update on August 14, 2023
04:05pm, Wednesday, 02'nd Aug 2023
SAN DIEGO, Aug. 02, 2023 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development pla
TRACON Pharmaceuticals to Present at the Maxim Group Healthcare Virtual Conference
08:00am, Friday, 16'th Jun 2023
SAN DIEGO, June 16, 2023 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted
TRACON Pharmaceuticals to Present at the Jefferies Healthcare Conference
08:00am, Friday, 02'nd Jun 2023
SAN DIEGO, June 02, 2023 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted
TRACON Pharmaceuticals, Inc. (TCON) Q1 2023 Earnings Call Transcript
10:18pm, Wednesday, 10'th May 2023
TRACON Pharmaceuticals, Inc. (NASDAQ:TCON ) Q1 2023 Earnings Conference Call May 10, 2023 4:30 PM ET Company Participants Charles Theuer - CEO, President & Director Scott Brown - CFO Conference Call P
Why Is TRACON Pharma (TCON) Stock Down 51% Today?
09:11am, Tuesday, 25'th Apr 2023
TRACON Pharmaceuticals (NASDAQ: TCON ) stock is falling on Tuesday following an update on a legal battle with I-Mab (NASDAQ: IMAB ). The bad news for TCON stock comes from a legal ruling favoring I-
